Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...
Pacific Specialist Healthcare has performed Fiji’s first open-heart surgery, achieving a 100 percent success rate and ...
The Valeda ® Light Delivery System (LumiThera, Inc.) is the first ever FDA-authorized treatment for vision loss in dry AMD, the manufacturer reported. The technology was evaluated in the LIGHTSITE III ...
Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.
A delay in the FDA decision for NT-501 could leave those with macular telangiectasia (MacTel) without any form of treatment ...
Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...
Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...
They found that giving ECPs first-hand experience of dry eye and cosmetic procedures creates the best kind of word-of-mouth ...
PHAT is a facial rejuvenation therapy that combines nanofat and its stem cells with PRP for anti-aging that lasts for more ...
Sharma underwent surgery yesterday for cataract shared his experience to raise awareness about the importance of early ...
PRFM (Platelet-Rich Fibrin Matrix) injectables can be used to thicken thinning skin, hollowness and even loss of volume.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback